DeepMed Research

THE MILTON S. HERSHEY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered Population

Completed

Conditions: Anorexia Nervosa
Bulimia Nervosa
Eating Disorder

First Posted Date: 2008-10-06

Last Posted Date: 2017-06-20

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 29

Registration Number: NCT00766558

Locations: 🇺🇸
Penn State College of Medicine, Hershey, Pennsylvania, United States

Intraoperative Angioembolization in the Management of Pelvic Fracture-Related Hemodynamic Instability

Completed

Conditions: Pelvic Fractures and Associated Hemodynamic Instability

First Posted Date: 2008-09-18

Last Posted Date: 2019-11-22

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 15

Registration Number: NCT00755365

Locations: 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Smoking Cessation in Nonunion, Malunion, Osseous Infection

Withdrawn

Conditions: Fracture Nonunion
Infection

First Posted Date: 2008-09-17

Last Posted Date: 2019-03-21

Lead Sponsor: Milton S. Hershey Medical Center

Registration Number: NCT00754299

Locations: 🇺🇸
The Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety

Not Applicable

Terminated

Conditions: Panic Disorder
Insomnia

Interventions: Drug: Ramelteon and Escitalopram
Drug: Placebo and Escitalopram

First Posted Date: 2008-09-03

Last Posted Date: 2018-05-30

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 11

Registration Number: NCT00746239

Locations: 🇺🇸
Penn State Hershey Medical Center, Hershey, Pennsylvania, United States

Effects of Intra-articular Versus Subacromial Steroid Injections on Clinical Outcomes in Adhesive Capsulitis

Not Applicable

Withdrawn

Conditions: Adhesive Capsulitis

Interventions: Drug: Lidocaine + Kenalog
Drug: Lidocaine

First Posted Date: 2008-08-28

Last Posted Date: 2015-02-27

Lead Sponsor: Milton S. Hershey Medical Center

Registration Number: NCT00742846

Locations: 🇺🇸
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers

Not Applicable

Completed

Conditions: Insulin Resistance
Diabetes Mellitus

Interventions: Drug: Olanzapine 10 mg po qhs for 3 days
Drug: Placebo

First Posted Date: 2008-08-25

Last Posted Date: 2014-07-14

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 15

Registration Number: NCT00741026

Locations: 🇺🇸
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Comparing Fluticasone-salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep

Phase 4

Completed

Conditions: COPD

Interventions: Drug: Advair 250
Drug: Placebo
Drug: Advair 250 - matched
Drug: Placebo- matched

First Posted Date: 2008-08-11

Last Posted Date: 2019-03-29

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 10

Registration Number: NCT00731770

Locations: 🇺🇸
Penn State Universuty, Hershey, Pennsylvania, United States

Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Drug: Raloxifene 60 Mg Oral Tablet
Drug: Raloxifene 30 Mg Oral Tablet
Dietary Supplement: Lovaza 4gm oral
Drug: Lovaza 4gm & Raloxifene 30mg

First Posted Date: 2008-07-28

Last Posted Date: 2018-11-01

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 266

Registration Number: NCT00723398

Locations: 🇺🇸
Penn State Hershey Medical Center, Hershey, Pennsylvania, United States

The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease

Phase 2

Completed

Conditions: Crohn's Disease

Interventions: Other: Placebo, sugar pill
Drug: Naltrexone

First Posted Date: 2008-07-15

Last Posted Date: 2018-09-06

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 14

Registration Number: NCT00715117

Locations: 🇺🇸
Penn State University hershey Medical center, Hershey, Pennsylvania, United States

Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer

Phase 1

Terminated

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Bortezomib
Drug: Carboplatin
Drug: Docetaxel

First Posted Date: 2008-07-14

Last Posted Date: 2019-06-24

Lead Sponsor: Milton S. Hershey Medical Center

Target Recruit Count: 6

Registration Number: NCT00714246

Locations: 🇺🇸
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy